Evidence synthesis serves as a bridge between clinical practice and the best available evidence. Evidence synthesis based on high-quality randomized controlled trials is generally considered the highest level of evidence, but its external validity is limited. In some scenarios, the inclusion of non-randomized intervention studies (NRSI) in evidence synthesis may further supplement or even replace randomized controlled trial evidence, such as assessing intervention effectiveness and rare events in a broader population to provide more information for health care decision-making. With the rapid development of real-world data and the improvement of statistical analysis methods, real-world evidence, as an important source of evidence for NRSI, has accelerated the development of high-quality NRSI. However, there are numerous challenges in integrating evidence from randomized and non-randomized intervention studies due to selection and confounding biases caused by the lack of randomization. Based on previous studies, this paper systematically examines the current status of integrated randomized and non-randomized intervention studies, including integration premise, timing, methods, and result interpretation, in order to provide references for researchers and policy-makers to correctly use non-randomized research evidence and further promote optimal evidence generation and clinical practice translation.